Summary
CRISPR pools are being widely employed to identify gene functions.
However, current technology, which utilizes DNA as barcodes, permits limited
phenotyping and bulk-cell resolution. To enable novel screening capabilities, we
developed a barcoding system operating at the protein level. We synthesized
modules encoding triplet combinations of linear epitopes to generate >100
unique protein barcodes (Pro-Codes). ProCode-expressing vectors were introduced
into cells and analyzed by CyTOF mass-cytometry. Using just 14 antibodies, we
detected 364 Pro-Code populations; establishing the largest set of protein-based
reporters. By pairing each Pro-Code with a different CRISPR, we simultaneously
analyzed multiple phenotypic markers, including phospho-signaling, on dozens of
knockouts. Pro-Code/CRISPR screens found two interferon-stimulated genes, the
immunoproteasome component Psmb8 and a chaperone Rtp4, are important for
antigen-dependent immune editing of cancer cells, and identified Socs1 as a
negative regulator of Pd-l1. The Pro-Code technology enables simultaneous
high-dimensional protein-level phenotyping of 100s of genes with single cell
resolution.
L. provided samples. M.M. designed and supervised the research, analyzed data, and edited the manuscript. J.D.B. analyzed data and edited the manuscript. B.D.B. designed and supervised the research, analyzed data and wrote the manuscript. COMPETING INTERESTS J.M.S. is an employee and stockholder of Qiagen Sciences. J.D.B. holds patents related to ATAC-seq and is on the scientific advisory board for Camp4, Seqwell, and Celsee. The remaining authors have no competing interests.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.